Carillon Tower Advisers’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	$17.1M	Hold	178,671	–	–	0.1%	276
2020 Q3	$17.2M	Buy	178,671 +49,071	+38%	+$4.72M	0.23%	166
2020 Q2	$15.8M	Buy	+129,600	New	+$15.8M	0.12%	237